News|Videos|June 13, 2023
Transduction for AAV with Sean Hart
Author(s)Chris Spivey
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.
Advertisement
Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
BBB-Crossing Tech for Lysosomal Storage Disorders at Center of Chiesi–Aliada Partnership
2
UK’s Persistent Failure to Commercialize R&D Threatens Life Sciences: Report
3
At AAPS PharmSci 360, Solutions for Challenges in Amorphous Solid Dispersion Development
4
PharmTech Weekly News Roundup — Week of November 10, 2025
5
